Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 8 , ISSUE 1 ( January-March, 2016 ) > List of Articles

RESEARCH ARTICLE

Comparison of Levels of Androgenic Hormones in various Phenotypes of Polycystic Ovarian Syndrome in High School Girls aging 14 to 18 Years

Marzieh Akbarzadeh, Tahereh Naderi, Mohammad H Dabbaghmaneh, Hamidreza Tabatabaee

Citation Information : Akbarzadeh M, Naderi T, Dabbaghmaneh MH, Tabatabaee H. Comparison of Levels of Androgenic Hormones in various Phenotypes of Polycystic Ovarian Syndrome in High School Girls aging 14 to 18 Years. J South Asian Feder Obs Gynae 2016; 8 (1):33-39.

DOI: 10.5005/jp-journals-10006-1382

Published Online: 01-06-2013

Copyright Statement:  Copyright © 2016; The Author(s).


Abstract

PDF Share
  1. Comparison of the phenotype of Chinese versus Dutch Caucasian women presenting with polycystic ovary syndrome and oligo/amenorrhoea. Hum Reprod 2012;27(5):1481-1488.
  2. A survey of metabolic syndrome in first-degree relatives (fathers) of patients with polycystic ovarian syndrome, JEMDSA 2013;18(2):98-103.
  3. Phenotype and metabolic disorders in polycystic ovary syndrome. International Scholarly Research Network. ISRN Endocrinol 2012;569862. doi: 10.5402/2012/569862.
  4. Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndrome. Clin Exp Reprod Med. 2013;40(2):100-105.
  5. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. Hum Reprod 2009;24(9): 2286-2292.
  6. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Indian J Endocrinol Metab 2014 May;18(3):317-324.
  7. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Pol 2011;62(3):238-242.
  8. The Association of obesity and hyperandrogenemia during the pubertal transition in girls. J Clin Endocrin Metabolism 2005;91(5): 1714-1722.
  9. Progesterone inhibition of the hypothalamic gonadotropin—releasing hormone pulse generator: evidence for varied effects in hyperandrogenic adoplescent girls. J Clin Endocrinol Metab 2005;90(5):2810-2815.
  10. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril 2009; 92(2):626-634.
  11. Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 2007;92(3):787-796.
  12. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81(1):19-25.
  13. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Hum Reprod 2008 Aug;23(8):1924-1931.
  14. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Hum Reprod 2012 Feb;27(2):541-549.
  15. Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol (Oxf) 2007;67(5):735-742.
  16. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population. Gynecol Endocrinol Gynecol Endocrinol 2007; 23(10):604-609.
  17. Risk of metabolic complications in the new PCOS phenotype based on the Rotterdam criteria. Fertil Steril 2007;88(5):1389-1395.
  18. Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes. Endocrine 2011 Jun;39(3):272-277.
  19. Polycystic ovary syndrome in girls aged 14-18 years in Isfahan, Iran. Horm Res 2004;62(6): 278-282.
  20. Clinical assessment of body hair growth in women. Endocr Rev 2000;21(4):347-362.
  21. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977 Sep;97(3):247-257.
  22. Gynecology. 13th ed. Philadelphia: Waverly; 2007. p. 149-172.
  23. Prevalence of polycystic ovaries in women with idiopathic hirsutism. Br Med J (Clin Res Ed). 1986;9;293(6543):355-359.
  24. IVF outcome in women with PCOS, PCO and normal ovarian morphology. Eur J Obstet Gynecol Reprod Biol 2010;149(1):68-71.
  25. Trasvaginal ultasound imaging, histopatology and endocrinopathy in patient with polycystic ovarian syndrome. Hum Reprod 1994;9(7):1231-1236.
  26. Polycystic ovary syndrome. N Engl J Med 2005 Mar 24;352(12):1223-1236.
  27. Endocrin Disorder. Novak's Gynecology. In: Berek JS, editor. Lippincott Williams & Wilkins; 2002. p. 871-917.
  28. Recovery of hormon secretion after chronic gonadotropin-releasing hormon agonist administration in women with PCO disease. J Clin Endocrinol Metab 1989;68(6):1111-1117.
  29. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab, 1983;57(2):393-397.
  30. Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormon, androgens and insulin. Fertil Steril, 2000;74(1):49-58.
  31. How possible is the prevention of PCO develope in adolescent patients with early onset of hyperandrogenism. Endocrinol Invest 1998;21(9):613-617.
  32. Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2014 Sep;81(3):426-431.
  33. [Adrenal androgen participation in the polycystic ovary syndrome]. Rev Bras Ginecol Obstet 2010 Nov;32(11):541-548.
  34. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertility and sterility 2002;77(6):1095-1105.
  35. Novak ‘s gynecology, 12th ed, Philadelphia, Lippincott Williams & Wilkins; 2002. p. 158-160.
  36. Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. J Clin Endocrinol Metab 2006 Oct;91(10):3922-3927.
  37. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes. Fertil Steril 2010;94(6):2197-2201.
  38. The prevalence of the polycystic ovaries on ultrasound scanning in a population of randomly selected women. Aust NZ J Obstet Gynaecol 1994;34(1):67-72.
  39. Clinical characteristics, laboratory and ultrasound polycystic ovary syndrome in Kerman. Journal of Endocrinology and Metabolism University of Medical Sciences and Health Services Beheshti 2004;6(2):153-161. (persion)
  40. Polycystic ovarian syndrome: clinical and laboratory evaluation. Sao Paulo Med J 1996;114(4):1222-1225.
  41. Endocrine features of polycystic ovary syndrome in an random population sample of 14-16 years old adolescents. Hum reprod 1999;14(9):2223-2229.
  42. Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril 2010;93(6):1938-1941.
  43. The combination of increased ovarian volume and follicle number is associated with more severe hyperandrogenism in German women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006 Apr;114(4): 175-181.
  44. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. J Clin Endocrinol Metab 2005 May;90(5):2571-2579.
  45. Use of insulin sensitizers in polycystic ovarian syndrome. Curr Opin Investig Drugs 2005 Oct;6(10):1012-1022.
  46. Prevalence of metabolic disorders among family member of patiens with polycystic ovary syndrome. The Journal of Review Medical Chil 2001;129(7):707-712.
  47. Hypernisulinemia is common in family members of women with polcystic ovary syndrome. Fertil Steril 1996 Dec;66(6):942-947.
  48. Glucose intolerance, insulin resistance and hyprandrogenemia in first degree relatives of woman with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88(5):2031-2036.
  49. Insulin resistance in first-degree relatives of the patients with polycystic ovarian syndrome. IJDO 2013;5(4):163-170.
  50. Metabolic syndrome and Ischemic heart disease in elderly men and women. Am J Epidemiol 2001 Mar 1;153(5):481-489.
  51. Prevalence of metabolic syndrome related disorder in a large adult population in Turkey. BMC Public Health 2006 Apr 10;6:92.
  52. Premenarcheal endocrine change in relation to age at menarche. Clin Endocrinol (Oxf) 1985;22(6):753-760.
  53. The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study. Reprod Biol Endocrinol 2011 Nov; 9:144.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.